Latest filing published 03 Aug 2026 for Identiv, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard Kuntz (senior executive) discloses dealings in 3 companies, chiefly INVE Technologies, Inc., DiaMedica Therapeutics Inc. and Medtronic plc. The record holds 9 filings, for trades running from 2 August 2021 to 30 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 3 August 2026, reports a share grant in INVE Technologies, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations